Literature DB >> 23476054

Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry.

Luigi Tavazzi1, Michele Senni, Marco Metra, Marco Gorini, Giuseppe Cacciatore, Alessandra Chinaglia, Andrea Di Lenarda, Andrea Mortara, Fabrizio Oliva, Aldo P Maggioni.   

Abstract

BACKGROUND: Clinical observational studies on heart failure (HF) deal mostly with hospitalized patients, few with chronic outpatients, all with no or limited longitudinal observation. METHODS AND
RESULTS: This is a multicenter, nationwide, prospective observational trial on a population of 5610 patients, 1855 hospitalized for acute HF (AHF) and 3755 outpatients with chronic HF (CHF), followed up for 1 year. The cumulative total mortality rate at 1 year was 24% in AHF (19.2% in 797 patients with de novo HF and 27.7% in 1058 with worsening HF) and 5.9% in CHF. Cardiovascular deaths accounted for 73.1% and 65.3% and HF deaths for 42.4% and 40.5% of total deaths in AHF and CHF patients, respectively. One-year hospitalization rates were 30.7% in AHF and 22.7% in CHF patients. Among the independent predictors of 1-year all-cause death, age, low systolic blood pressure, anemia, and renal dysfunction were identified in both acute and chronic patients. A few additional variables were significant only in AHF (signs of cerebral hypoperfusion, low serum sodium, chronic obstructive pulmonary disease, and acute pulmonary edema), whereas others were observed only in CHF patients (lower body mass index, higher heart rate, New York Heart Association class, large QRS, and severe mitral regurgitation).
CONCLUSIONS: In this contemporary data set, patients with CHF had a relatively low mortality rate compared with those with AHF. Rates of adverse outcomes in patients admitted for AHF remain very high either in-hospital or after discharge. Most deaths were cardiovascular in origin and ≈40% of deaths were directly related to HF.

Entities:  

Keywords:  epidemiology; heart failure; prognosis

Mesh:

Year:  2013        PMID: 23476054     DOI: 10.1161/CIRCHEARTFAILURE.112.000161

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  36 in total

1.  Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.

Authors:  Willemien J Kruik-Kollöffel; Gerard C M Linssen; H Joost Kruik; Kris L L Movig; Edith M Heintjes; Job van der Palen
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

Review 2.  Trials of implantable monitoring devices in heart failure: which design is optimal?

Authors:  William T Abraham; Wendy G Stough; Ileana L Piña; Cecilia Linde; Jeffrey S Borer; Gaetano M De Ferrari; Roxana Mehran; Kenneth M Stein; Alphons Vincent; Jay S Yadav; Stefan D Anker; Faiez Zannad
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

Review 3.  Improving Postdischarge Outcomes in Acute Heart Failure.

Authors:  Ovidiu Chioncel; Sean P Collins; Andrew P Ambrosy; Peter S Pang; Elena-Laura Antohi; Vlad Anton Iliescu; Aldo P Maggioni; Javed Butler; Alexandre Mebazaa
Journal:  Am J Ther       Date:  2018 Jul/Aug       Impact factor: 2.688

4.  The Burden of Chronic Heart Failure in Primary Care in Italy.

Authors:  Carlo Piccinni; Ippazio Cosimo Antonazzo; Monica Simonetti; Marco Giovanni Mennuni; Damiano Parretti; Claudio Cricelli; Delia Colombo; Mihaela Nica; Iacopo Cricelli; Francesco Lapi
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-03-21

5.  Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry.

Authors:  W von Scheidt; C Zugck; M Pauschinger; R Hambrecht; O Bruder; A Hartmann; M Rauchhaus; R Zahn; J Brachmann; U Tebbe; T Neumann; R H Strasser; M Böhm; S Störk; M Hochadel; P Heidemann; J Senges
Journal:  Clin Res Cardiol       Date:  2014-07-23       Impact factor: 5.460

6.  Predictors of Post-discharge Mortality Among Patients Hospitalized for Acute Heart Failure.

Authors:  Ovidiu Chioncel; Sean P Collins; Stephen J Greene; Peter S Pang; Andrew P Ambrosy; Elena-Laura Antohi; Muthiah Vaduganathan; Javed Butler; Mihai Gheorghiade
Journal:  Card Fail Rev       Date:  2017-11

Review 7.  Pediatric heart failure: current state and future possibilities.

Authors:  Joseph W Rossano; Gi Young Jang
Journal:  Korean Circ J       Date:  2015-01-26       Impact factor: 3.243

8.  Association of Heart Rate Trajectory Patterns with the Risk of Adverse Outcomes for Acute Heart Failure in a Heart Failure Cohort in Taiwan.

Authors:  Cheng-Chun Wei; Kou-Gi Shyu; Kuo-Liong Chien
Journal:  Acta Cardiol Sin       Date:  2020-09       Impact factor: 2.672

9.  Association of early left ventricular dysfunction with advanced magnetic resonance white matter and gray matter brain measures: The CARDIA study.

Authors:  Anderson C Armstrong; Majon Muller; Bharath Ambale-Venkatesh; Michael Halstead; Satoru Kishi; Nick Bryan; Stephen Sidney; Luís C L Correia; Samuel S Gidding; Lenore J Launer; João A C Lima
Journal:  Echocardiography       Date:  2017-11-08       Impact factor: 1.874

10.  Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.

Authors:  Piotr Ponikowski; Dirk J van Veldhuisen; Josep Comin-Colet; Georg Ertl; Michel Komajda; Viacheslav Mareev; Theresa McDonagh; Alexander Parkhomenko; Luigi Tavazzi; Victoria Levesque; Claudio Mori; Bernard Roubert; Gerasimos Filippatos; Frank Ruschitzka; Stefan D Anker
Journal:  Eur Heart J       Date:  2014-08-31       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.